首页> 美国卫生研究院文献>The Journal of Biophysical and Biochemical Cytology >Topology of sphingolipid galactosyltransferases in ER and Golgi: transbilayer movement of monohexosyl sphingolipids is required for higher glycosphingolipid biosynthesis
【2h】

Topology of sphingolipid galactosyltransferases in ER and Golgi: transbilayer movement of monohexosyl sphingolipids is required for higher glycosphingolipid biosynthesis

机译:内质网和高尔基体中的鞘脂半乳糖基转移酶的拓扑结构:高糖鞘脂生物合成需要单己糖鞘脂的跨双层运动

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Glucosylceramide (GlcCer) is synthesized at the cytosolic surface of the Golgi complex while enzymes acting in late steps of glycosphingolipid biosynthesis have their active centers in the Golgi lumen. However, the topology of the "early" galactose-transferring enzymes is largely unknown. We used short-chain ceramides with either an 2-hydroxy fatty acid (HFA) or a normal fatty acid (NFA) to determine the topology of the galactosyltransferases involved in the formation of HFA- and NFA-galactosylceramide (GalCer), lactosylceramide (LacCer), and galabiosylceramide (Ga2Cer). Although the HFA-GalCer synthesizing activity colocalized with an ER marker, the other enzyme activities fractionated at the Golgi density of a sucrose gradient. In cell homogenates and permeabilized cells, newly synthesized short-chain GlcCer and GalCer were accessible to serum albumin, whereas LacCer and Ga2Cer were protected. From this and from the results obtained after protease treatment, and after interfering with UDP-Gal import into the Golgi, we conclude that (a) GlcCer and NFA-GalCer are synthesized in the cytosolic leaflet, while LacCer and Ga2Cer are synthesized in the lumenal leaflet of the Golgi. (b) HFA-GalCer is synthesized in the lumenal leaflet of the ER, but has rapid access to the cytosolic leaflet. (c) GlcCer, NFA-GalCer, and HFA-GalCer translocate from the cytosolic to the lumenal leaflet of the Golgi membrane. The transbilayer movement of GlcCer and NFA-GalCer in the Golgi complex is an absolute requirement for higher glycosphingolipid biosynthesis and for the cell surface expression of these monohexosyl sphingolipids.
机译:葡萄糖基神经酰胺(GlcCer)在高尔基体的胞质表面合成,而在糖鞘脂生物合成后期阶段起作用的酶在高尔基体腔中具有活性中心。然而,“早期”的半乳糖转移酶的拓扑结构在很大程度上是未知的。我们使用短链神经酰胺与2-羟基脂肪酸(HFA)或正脂肪酸(NFA)来确定参与形成HFA-和NFA-半乳糖基神经酰胺(GalCer),乳糖基神经酰胺(LacCer)的半乳糖基转移酶的拓扑)和加拉波西酰神经酰胺(Ga2Cer)。尽管HFA-GalCer的合成活性与ER标记共定位,但其他酶的活性在蔗糖梯度的高尔基密度上分级。在细胞匀浆和透化细胞中,新合成的短链GlcCer和GalCer可接触血清白蛋白,而LacCer和Ga2Cer受保护。由此和蛋白酶处理后以及干扰UDP-Gal导入高尔基体后获得的结果,我们得出以下结论:(a)GlcCer和NFA-GalCer在胞浆小叶中合成,而LacCer和Ga2Cer在腔内合成高尔基的传单。 (b)HFA-GalCer在ER的内腔小叶中合成,但可快速进入胞质小叶。 (c)GlcCer,NFA-GalCer和HFA-GalCer从胞质转移到高尔基体膜的腔小叶。 GlcCer和NFA-GalCer在高尔基体中的双分子层运动是更高糖鞘脂生物合成和这些单己糖基鞘脂的细胞表面表达的绝对要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号